XIST Inhibition Attenuates Calcium Oxalate Nephrocalcinosis-Induced Renal Inflammation and Oxidative Injury via the miR-223/NLRP3 Pathway.


Journal

Oxidative medicine and cellular longevity
ISSN: 1942-0994
Titre abrégé: Oxid Med Cell Longev
Pays: United States
ID NLM: 101479826

Informations de publication

Date de publication:
2021
Historique:
received: 21 04 2021
revised: 04 07 2021
accepted: 06 08 2021
entrez: 13 9 2021
pubmed: 14 9 2021
medline: 19 2 2022
Statut: epublish

Résumé

The roles of the lncRNA X inactive specific transcript (XIST) in many diseases, including cancers and inflammatory sickness, have been previously elucidated. However, renal calculus remained poorly understood. In this study, we revealed the potential effects of XIST on kidney stones that were exerted via inflammatory response and oxidative stress mechanisms. We established a glyoxylate-induced calcium oxalate (CaOx) stone mouse model and exposed HK-2 cells to calcium oxalate monohydrate (COM). The interactions among XIST, miR-223-3p, and NOD-like receptor protein 3 (NLRP3) and their respective effects were determined by RNAs and protein expression, luciferase activity, and immunohistochemistry (IHC) assays. Cell necrosis, reactive oxygen species (ROS) generation, and inflammatory responses were detected after silencing XIST, activating and inhibiting miR-223-3p, and both knocking down XIST and activating miR-223-3p in vitro and in vivo. The XIST, NLRP3, caspase-1, and IL-1

Identifiants

pubmed: 34512861
doi: 10.1155/2021/1676152
pmc: PMC8429007
doi:

Substances chimiques

MIRN223 microRNA, human 0
MIRN223 microRNA, mouse 0
MicroRNAs 0
NLR Family, Pyrin Domain-Containing 3 Protein 0
NLRP3 protein, human 0
Nlrp3 protein, mouse 0
RNA, Long Noncoding 0
XIST non-coding RNA 0
Calcium Oxalate 2612HC57YE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1676152

Informations de copyright

Copyright © 2021 Peng Lv et al.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Genet. 2018 Jun;50(6):783-789
pubmed: 29785014
Genes Dev. 2020 Jun 1;34(11-12):733-744
pubmed: 32482714
Nat Rev Cardiol. 2018 Sep;15(9):505-522
pubmed: 30065258
Biochem Biophys Res Commun. 2020 Jan 15;521(3):791-798
pubmed: 31703838
EBioMedicine. 2019 Dec;50:366-378
pubmed: 31735555
Cell Death Differ. 2007 Sep;14(9):1590-604
pubmed: 17599095
Cell Mol Life Sci. 2021 Jan;78(1):299-316
pubmed: 32193609
J Exp Clin Cancer Res. 2019 Jan 24;38(1):32
pubmed: 30678736
Nat Rev Mol Cell Biol. 2016 Dec;17(12):756-770
pubmed: 27780979
J Cell Biochem. 2017 Oct;118(10):3349-3358
pubmed: 28295543
Cell Mol Gastroenterol Hepatol. 2017 Jul 19;4(3):329-337
pubmed: 28884136
Int J Clin Exp Pathol. 2019 Jul 01;12(7):2425-2434
pubmed: 31934069
Circulation. 2012 Jun 12;125(23):2892-903
pubmed: 22580331
Nature. 1992 Apr 30;356(6372):768-74
pubmed: 1574116
Kidney Int. 2018 Mar;93(3):656-669
pubmed: 29241624
J Clin Invest. 2005 Oct;115(10):2598-608
pubmed: 16200192
J Immunol. 2011 Feb 15;186(4):2495-502
pubmed: 21239716
J Exp Med. 2017 Jun 5;214(6):1737-1752
pubmed: 28487310
Transl Androl Urol. 2014 Sep 1;3(3):256-276
pubmed: 25383321
Nephrol Dial Transplant. 2014 Mar;29(3):507-14
pubmed: 24163269
Nature. 2014 Jan 16;505(7483):344-52
pubmed: 24429633
Nature. 2006 Mar 9;440(7081):237-41
pubmed: 16407889
Nat Rev Genet. 2009 Mar;10(3):155-9
pubmed: 19188922
J Histochem Cytochem. 1964 May;12:333-6
pubmed: 14193854
J Cell Physiol. 2018 Mar;233(3):2116-2132
pubmed: 28345767
Mol Ther Nucleic Acids. 2019 Dec 6;18:764-773
pubmed: 31734557
Cancer Sci. 2017 Oct;108(10):1927-1933
pubmed: 28776911
Front Pharmacol. 2015 Nov 05;6:262
pubmed: 26594174
J Leukoc Biol. 2018 Sep;104(3):515-524
pubmed: 29969525
Nature. 2010 Apr 29;464(7293):1357-61
pubmed: 20428172
Nat Genet. 2001 Nov;29(3):301-5
pubmed: 11687797
Nat Commun. 2017 Aug 18;8(1):289
pubmed: 28819095
Urol Res. 2007 Apr;35(2):89-99
pubmed: 17393196
J Clin Invest. 2013 Jan;123(1):236-46
pubmed: 23221343
Mol Ther Nucleic Acids. 2019 Dec 6;18:801-814
pubmed: 31734560
Pediatr Nephrol. 2010 May;25(5):831-41
pubmed: 19198886
J Cell Physiol. 2020 Jan;235(1):281-293
pubmed: 31215024
Inflammation. 2021 Feb;44(1):194-205
pubmed: 32812145
Nature. 2008 Feb 28;451(7182):1125-9
pubmed: 18278031
PLoS Genet. 2019 Sep 19;15(9):e1008333
pubmed: 31537017
Sci Rep. 2017 Jan 31;7:41630
pubmed: 28139722
Diabetes Res Clin Pract. 2014 Aug;105(2):141-50
pubmed: 24798950
Clin Exp Rheumatol. 2016 Jul-Aug;34(4 Suppl 98):12-6
pubmed: 27586797
J Urol. 2015 May;193(5):1684-91
pubmed: 25437532

Auteurs

Peng Lv (P)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Haoran Liu (H)

Department of Urology, The First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University, Hefei, China.
Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Tao Ye (T)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Xiaoqi Yang (X)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Chen Duan (C)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Xiangyang Yao (X)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Bo Li (B)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Kun Tang (K)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zhiqiang Chen (Z)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Jianhe Liu (J)

Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.

Yaoliang Deng (Y)

Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.

Tao Wang (T)

Department of Urology, The First Affiliated Hospital of Xiamen University, Xiamen, China.

Jinchun Xing (J)

Department of Urology, The First Affiliated Hospital of Xiamen University, Xiamen, China.

Chaozhao Liang (C)

Department of Urology, The First Affiliated Hospital of Anhui Medical University, Institute of Urology, Anhui Medical University, Hefei, China.

Hua Xu (H)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Zhangqun Ye (Z)

Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH